Effect of Structured Education for Family Members of Intensive Care Patients Undergoing Tracheostomy
NCT07737353
Anxiety Disorders, Behavior
Giresun, Turkey (Türkiye)
View Trial DetailsNCT Number: NCT02766166
CHAOS is based on the investigator's new and exciting results from pre-clinical and large longitudinal multi-center observational clinical studies of critically ill patients and asymptomatic community-based adults with little or no advanced disease.
By integrating approaches from the physical, biological, computational, statistical and clinical sciences, this observational study will test the hypothesis that early diagnosis of subclinical signatures of critical illness encoded within physiological signals complements conventional clinical predictors by providing unique prognostic insight.
The primary goal is to reduce mortality, morbidity and complications by early identification of individuals with brewing subclinical critical illness and adverse events before overt clinical presentation (e.g., cardiac arrest, arrhythmias, hemorrhage, respiratory failure, circulatory collapse). This will provide the necessary lead time for healthcare providers to deliver early, more effective and/or preventive therapies. Through innovative approaches, CHAOS also meets the challenge of medical errors to reduce missed diagnosis, misdiagnosis, preventable harm and variability in provider adherence to best practice guidelines.
The goal is to validate predictive algorithms and identify subclinical signatures of illness, ranging from asymptomatic adults in the community to very sick patients in the hospital. The overall goal is to make healthcare more precise, effective, efficient, safe and timely while reducing costs, preventable harms and adverse events.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Indiana University, Indianapolis, Indiana, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Time frame: From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months
Time frame: through study completion, an average of 1 year
Time frame: through study completion, an average of 1 year
Time frame: 30 days
Contact information is provided by the study sponsor or research team.
Deeptankar DeMazumder, MD, PhD
CONTACT
Deeptankar DeMazumder, MD, PhD
CONTACT
Johns Hopkins University
Other
Acronym: CHAOS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07737353
Anxiety Disorders, Behavior
Giresun, Turkey (Türkiye)
View Trial DetailsNCT06728722
Atrophy, Critical Illness
Cairo, Cairo Governorate, Egypt
View Trial DetailsNCT07722897
Critical Illness, Disease Attributes
Antalya, Turkey (Türkiye)
View Trial DetailsNCT06588556
Care Delivery Model, Critical Illness
Birmingham, Alabama, United States
View Trial Details